|
|
Editorial |
| Cellular resistance mechanisms with impact on the therapy of multiple myeloma |
1009 |
| F Gieseler & V Nüßler
|
|
Abstract
Full Article (PDF)
|
|
Review |
| The study of apoptotic cells by flow cytometry |
1013 |
| MG Ormerod
|
|
Abstract
Full Article (PDF)
|
|
Mini-Review |
| Large cell lymphoma complicating persistent polyclonal B cell lymphocytosis |
1026 |
| J Roy,
C Ryckman,
V Bernier,
R Whittom & R Delage
|
|
Abstract
Full Article (PDF)
|
|
Original Manuscripts, Therapy And Therapeutic Interventions |
| Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI |
1031 |
| S Richards,
J Burrett,
I Hann,
J Chessells,
F Hill,
C Bailey
for the Medical Research Council Working Party on Childhood Leukemia
|
|
Abstract
Full Article (PDF)
|
|
| Phase II study of carboplatin in blast crisis of chronic myeloid leukemia: Eastern Cooperative Oncology Group Study E1992 |
1037 |
| JP Dutcher,
S Lee,
E Paietta,
JM Bennett,
JA Stewart & PH Wiernik
|
|
Abstract
Full Article (PDF)
|
|
| Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group |
1041 |
| E Elonen,
A Almqvist,
A Hänninen,
S-E Jansson,
G Järventie,
P Koistinen,
E Koivunen,
R Lahtinen,
M Lehtinen,
T Nousiainen,
T-T Pelliniemi,
A Rajamäki,
K Remes,
T Timonen,
J Vilpo,
L Volin & T Ruutu
|
|
Abstract
Full Article (PDF)
|
|
| Superiority of high-dose over intermediate-dose cytosine arabinoside in the treatment of patients with high-risk acute myeloid leukemia: results of an age-adjusted prospective randomized comparison |
1049 |
| W Kern,
C Aul,
G Maschmeyer,
R Schönrock-Nabulsi,
WD Ludwig,
A Bartholomäus,
P Bettelheim,
B Wörmann,
T Büchner,
W Hiddemann
for the German AML Cooperative Group
|
|
Abstract
Full Article (PDF)
|
|
Clinical-Laboratory Correlates |
| Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia |
1056 |
| A Venditti,
G Del Poeta,
F Buccisano,
A Tamburini,
MC Cox-Froncillo,
G Aronica,
A Bruno,
B Del Moro,
AM Epiceno,
A Battaglia,
L Forte,
M Postorino,
V Cordero,
S Santinelli & S Amadori
|
|
Abstract
Full Article (PDF)
|
|
| Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity |
1064 |
O Hru ák,
J Trka,
J Zuna,
J Housková,
J Bart  ková,
J Starý
for the Pediatric Hematology Working Group in the Czech Republic
|
|
Abstract
Full Article (PDF)
|
|
Classification Of Acute Myeloid Leukemias |
| Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics |
1071 |
| N Villamor,
M-A Zarco,
M Rozman,
J-M Ribera,
E Feliu & E Montserrat
|
|
Abstract
Full Article (PDF)
|
|
Minimal Residual Disease In CML |
Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon  therapy? |
1076 |
| F Brizard,
JC Chomel,
A Veinstein,
J Rivet,
C Giraud,
A Kitzis,
F Guilhot & A Brizard
|
|
Abstract
Full Article (PDF)
|
|
Molecular Immunology In ALL |
| Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease |
1081 |
| T Szczepaski,
AW Langerak,
ILM Wolvers-Tettero,
GJ Ossenkoppele,
G Verhoef,
M Stul,
EJ Petersen,
MAC de Bruijn,
MB van’t Veer & JJM van Dongen
|
|
Abstract
Full Article (PDF)
|
|
Hematopoietic Receptor Genes |
| Specific and common activities of the FLT3 and KIT tyrosine kinase receptors revealed by the use of cultured mast cells |
1089 |
| N Casteran,
N Beslu,
E Lecocq,
S Gomez & P Dubreuil
|
|
Abstract
Full Article (PDF)
|
|
Molecular Cytogenetics |
| Abnormalities of the ETV6 gene occur in the majority of patients with aberrations of the short arm of chromosome 12: a combined PCR and Southern blotting analysis |
1099 |
| HE O’Connor,
TA Butler,
R Clark,
S Swanton,
CJ Harrison,
LM Secker-Walker & L Foroni
|
|
Abstract
Full Article (PDF)
|
|
| High-resolution allelotype analysis of childhood B-lineage acute lymphoblastic leukemia |
1107 |
| C Chambon-Pautas,
H Cavé,
B Gérard,
C Guidal-Giroux,
M Duval,
E Vilmer & B Grandchamp
|
|
Abstract
Full Article (PDF)
|
|
Tumor Suppressor Genes, Signal Transduction And Cell Cycle |
| Mutational analysis of the tumor suppressor Smad2 in acute lymphoid and myeloid leukemia |
1114 |
| R Wieser,
B Gruber,
H Rieder & C Fonatsch
|
|
Abstract
Full Article (PDF)
|
|
Megakaryocytopoiesis And MLL Amplification |
| Establishment and characterization of a megakaryoblast cell line with amplification of MLL |
1119 |
| RJ Allen,
SD Smith,
RL Moldwin,
M-M Lu,
L Giordano,
C Vignon,
Y Suto,
A Harden,
R Tomek,
T Veldman,
T Ried,
RA Larson,
MM Le Beau,
JD Rowley & N Zeleznik-Le
|
|
Abstract
Full Article (PDF)
|
|
Stromal Cell Biology: A Transgenic Mouse Model |
| Transplantation of stromal cells transduced with the human IL3 gene to stimulate hematopoiesis in human fetal bone grafts in non-obese, diabetic-severe combined immunodeficiency mice |
1128 |
| N Brouard,
A Chapel,
TMA Neildez-Nguyen,
C Granotier,
I Khazaal,
B Péault & D Thierry
|
|
Abstract
Full Article (PDF)
|
|
Matrix Metallo Proteinase |
| Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor- (TNF-) in NB4 leukemic cells: specific involvement of TNF receptor type 1 |
1136 |
| MG Ismair,
C Ries,
F Lottspeich,
C Zang,
HJ Kolb & PE Petrides
|
|
Abstract
Full Article (PDF)
|
|
Myeloma |
| Maintenance treatment with interferon alpha-2b in multiple myeloma: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology) |
1144 |
| J Bladé,
JF San Miguel,
ML Escudero,
M Fontanillas,
J Besalduch,
S Gardella,
J Arias,
J García-Conde,
M Carnero,
JM Marti,
C Rozman,
J Estapé & E Montserrat
|
|
Abstract
Full Article (PDF)
|
|
| In vitro excess ammonia production in human myeloma cell lines |
1149 |
| T Otsuki,
O Yamada,
H Sakaguchi,
T Ichiki,
K Kouguchi,
H Wada,
H Hata,
Y Yawata & A Ueki
|
|
Abstract
Full Article (PDF)
|
|
Brief Communication |
| Non-Hodgkin’s lymphomas and myeloid disorders: deletions associated with t(2;5) and t(3;5) detected by FISH |
1159 |
| M-A Dragon-Durey,
A-F Goguel,
C Leonard,
R Berger,
B Bressac-de-Paillerets,
D Fauvet & A Bernheim
|
|
Abstract
Full Article (PDF)
|
|
Correspondence |
| BCL6 rearrangement and mediastinal involvement in a case of B cell acute lymphoblastic leukemia |
1163 |
| JE Rubnitz,
B Abushullaih,
SC Kaste,
SC Raimondi,
JT Sandlund,
C-H Pui & FG Behm
|
|
Full Article (PDF)
|
|
| Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction - is it truly a benign disease? |
1166 |
| GF How,
LT Tan & LC Lim
|
|
Full Article (PDF)
|
|
| ETV6/ABL fusion is rare in Ph-negative chronic myeloid disorders |
1167 |
| T Nilsson,
P Andreasson,
M Höglund,
T Fioretos,
R Billström,
S Garwicz,
F Mitelman & B Johansson
|
|
Full Article (PDF)
|
|
Comments On Published Papers |
| SFT Thijsen et al. Hypersensitivity of bcr-abl progenitors to hyperthermia in patients with chronic myeloid leukemia |
1168 |
| M Baccarani
|
|
Full Article (PDF)
|
|
| Response to Michele Baccarani |
1169 |
| SFT Thijsen,
GJ Schuurhuis,
JW van Oostveen & GJ Ossenkoppele
|
|
Full Article (PDF)
|
|